Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL.

Sasaki K, Yamauchi T, Semba Y, Nogami J, Imanaga H, Terasaki T, Nakao F, Akahane K, Inukai T, Verhoeyen E, Akashi K, Maeda T
Blood. 2022 Feb 3;139(5):748-760. doi: 10.1182/blood.2021012976. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.